ATE223383T1 - Verfahren zur herstellung von 3-haloalkyl-1h- pyrazole - Google Patents

Verfahren zur herstellung von 3-haloalkyl-1h- pyrazole

Info

Publication number
ATE223383T1
ATE223383T1 AT96920420T AT96920420T ATE223383T1 AT E223383 T1 ATE223383 T1 AT E223383T1 AT 96920420 T AT96920420 T AT 96920420T AT 96920420 T AT96920420 T AT 96920420T AT E223383 T1 ATE223383 T1 AT E223383T1
Authority
AT
Austria
Prior art keywords
pyrazoles
haloalkyl
producing
adoption
safe
Prior art date
Application number
AT96920420T
Other languages
English (en)
Inventor
Benxin Zhi
Murad Newaz
John J Talley
Stephen Bertenshaw
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of ATE223383T1 publication Critical patent/ATE223383T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96920420T 1995-05-25 1996-05-23 Verfahren zur herstellung von 3-haloalkyl-1h- pyrazole ATE223383T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44997595A 1995-05-25 1995-05-25
PCT/US1996/007506 WO1996037476A1 (en) 1995-05-25 1996-05-23 Method of preparing 3-haloalkyl-1h-pyrazoles

Publications (1)

Publication Number Publication Date
ATE223383T1 true ATE223383T1 (de) 2002-09-15

Family

ID=23786237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96920420T ATE223383T1 (de) 1995-05-25 1996-05-23 Verfahren zur herstellung von 3-haloalkyl-1h- pyrazole

Country Status (20)

Country Link
US (2) US5892053A (de)
EP (1) EP0828717B1 (de)
JP (1) JP3996638B2 (de)
KR (1) KR100444802B1 (de)
CN (1) CN1174970C (de)
AT (1) ATE223383T1 (de)
AU (1) AU708964B2 (de)
BR (1) BR9609043A (de)
CA (1) CA2222138C (de)
CZ (1) CZ292320B6 (de)
DE (1) DE69623460T2 (de)
DK (1) DK0828717T3 (de)
ES (1) ES2182991T3 (de)
NO (1) NO311130B1 (de)
NZ (1) NZ308875A (de)
PL (1) PL187410B1 (de)
PT (1) PT828717E (de)
RO (1) RO118200B1 (de)
RU (2) RU2251543C2 (de)
WO (1) WO1996037476A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492411B1 (en) * 1993-11-30 2002-12-10 G. D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US5466823A (en) 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US6716991B1 (en) 1993-11-30 2004-04-06 G. D. Searle & Co. Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
ES2137138B1 (es) * 1998-05-29 2000-09-16 Esteve Labor Dr Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6727238B2 (en) * 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
JP2002534509A (ja) 1999-01-14 2002-10-15 メルク フロスト カナダ アンド カンパニー 4−[(5−置換または未置換フェニル)−3−置換−1h−ピラゾール−1−イル]ベンゼンスルホンアミド類の合成
KR100793668B1 (ko) * 1999-12-08 2008-01-10 파마시아 코포레이션 강화된 생체이용률을 지닌 고체상 형태의 셀레콕시브
HUP0201450A3 (en) * 1999-12-08 2003-02-28 Pharmacia Corp Chicago Solid-state form of celecoxib having enhanced bioavailability, pharmaceutical compositions containing it and their preparation
MY120279A (en) * 2000-05-26 2005-09-30 Pharmacia Corp Use of a celecoxib composition for fast pain relief
TR200001872A3 (tr) 2000-06-26 2002-01-21 Fako Ilaclari A.S 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem.
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
JP2004503601A (ja) * 2000-07-13 2004-02-05 ファルマシア・コーポレーション 眼のcox−2媒介疾患の処置及び予防におけるcox−2阻害剤の使用法
US20030219461A1 (en) * 2000-09-12 2003-11-27 Britten Nancy J. Parenteral combination therapy for infective conditions
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
PE20021017A1 (es) 2001-04-03 2002-11-24 Pharmacia Corp Composicion parenteral reconstituible
PL367337A1 (pl) * 2001-05-31 2005-02-21 Pharmacia Corporation Przenikająca przez skórę kompozycja selektywnego inhibitora cyklooksygenazy-2
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
WO2003091221A1 (en) * 2002-04-25 2003-11-06 Generics [Uk] Limited Celecoxib forms
US6864373B2 (en) * 2002-05-13 2005-03-08 Pharmacia Corporation Stable amorphous celecoxib composite and process therefor
MXPA04011654A (es) * 2002-05-24 2005-03-07 Pharmacia Corp Sintesis de diarilpirazoles.
JP2004115436A (ja) * 2002-09-26 2004-04-15 Nippon Nohyaku Co Ltd ピラゾール誘導体の製造方法
US20080153894A1 (en) * 2002-12-19 2008-06-26 Pharmacia Corporation Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050004098A1 (en) * 2003-03-20 2005-01-06 Britten Nancy Jean Dispersible formulation of an anti-inflammatory agent
AU2004222523A1 (en) * 2003-03-20 2004-09-30 Pharmacia Corporation Dispersible formulation of an anti-inflammatory agent
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
ES2257929B1 (es) * 2004-07-16 2007-05-01 Laboratorios Del Dr. Esteve, S.A. Derivados de pirazolina, procedimiento para su obtencion y utilizacion de los mismos como agentes terapeuticos.
EP1833476A1 (de) 2004-11-23 2007-09-19 PLIVA HRVATSKA d.o.o. Pharmazeutische zusammensetzung von celecoxib mit verlängerter freisetzung
WO2010095024A2 (en) 2009-02-20 2010-08-26 Aurobindo Pharma Limited An improved process for the preparation of celecoxib
WO2011055233A2 (en) 2009-11-03 2011-05-12 Actavis Group Ptc Ehf Improved process for preparing celecoxib polymorph
US20110213159A1 (en) 2010-03-01 2011-09-01 Vamsee Krishna Muppidi Process for preparation of celecoxib crystalline form
JP5909183B2 (ja) 2010-08-19 2016-04-26 国立大学法人 東京大学 オメガ3系脂肪酸由来の新規抗炎症性代謝物
CN102746231A (zh) * 2011-04-20 2012-10-24 天津药物研究院 塞来昔布制备工艺
CN103980201B (zh) * 2014-05-23 2016-02-10 苏州大学 一种含砜基的全取代吡唑的制备方法
CN110407683A (zh) * 2019-04-03 2019-11-05 湖南方盛制药股份有限公司 一种塞来昔布二酮中间体的制备方法
CN114292235B (zh) * 2021-12-29 2023-04-14 江苏天和制药有限公司 一种地拉考昔的制备和提纯方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA714221B (en) * 1970-07-10 1972-03-29 Astra Ab Insecticides
US3946057A (en) * 1972-05-03 1976-03-23 Union Carbide Corporation Preparation of metal complexes of 1,3-diketones
DE2429674A1 (de) * 1974-06-20 1976-01-08 Hoechst Ag Verfahren zur herstellung aromatischer 1,3-diketone
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Alkenyl or arylmethylene-substituted beta-diketones their preparation and pharmaceutical compositions containing them
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5344992A (en) * 1990-04-26 1994-09-06 Ciba-Geigy Corporation Process for the preparation of linear 1,3-diketones
KR0168056B1 (ko) * 1990-04-26 1999-03-20 베르너 발데크 선형 1,3-디케톤의 제조방법
IL104311A (en) * 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2701024B1 (fr) * 1993-02-01 1995-05-05 Rhone Poulenc Chimie Composant bétadicétonique pour additifs PVC, additif et PVC contenant ledit additif.
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
DE69422306T4 (de) * 1993-11-30 2000-09-07 G.D. Searle & Co., Chicago Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzündungen

Also Published As

Publication number Publication date
JPH11505848A (ja) 1999-05-25
EP0828717A1 (de) 1998-03-18
RU2251543C2 (ru) 2005-05-10
RO118200B1 (ro) 2003-03-28
CN1174970C (zh) 2004-11-10
WO1996037476A1 (en) 1996-11-28
AU708964B2 (en) 1999-08-19
CZ368997A3 (cs) 1998-03-18
PT828717E (pt) 2002-12-31
KR19990021966A (ko) 1999-03-25
DE69623460D1 (de) 2002-10-10
BR9609043A (pt) 1999-02-23
RU2169143C2 (ru) 2001-06-20
CA2222138C (en) 2008-10-14
EP0828717B1 (de) 2002-09-04
US5910597A (en) 1999-06-08
JP3996638B2 (ja) 2007-10-24
ES2182991T3 (es) 2003-03-16
MX9709065A (es) 1998-03-31
DK0828717T3 (da) 2003-01-06
KR100444802B1 (ko) 2004-12-17
PL323492A1 (en) 1998-03-30
CN1190960A (zh) 1998-08-19
AU5873696A (en) 1996-12-11
CA2222138A1 (en) 1996-11-28
NO311130B1 (no) 2001-10-15
NO975387L (no) 1997-12-17
NO975387D0 (no) 1997-11-24
NZ308875A (en) 1999-08-30
DE69623460T2 (de) 2003-02-27
CZ292320B6 (cs) 2003-09-17
PL187410B1 (pl) 2004-07-30
US5892053A (en) 1999-04-06

Similar Documents

Publication Publication Date Title
DE69623460D1 (de) Verfahren zur herstellung von 3-haloalkyl-1h-pyrazole
ATE226949T1 (de) Verfahren zur herstellung von tolterodin
DE69620461D1 (de) Verfahren zur herstellung von 1,1,1,3,3,-pentafluoropropanen
DE59607301D1 (de) Verfahren zur Herstellung von photopolymeren Hochdruckplatten
DE59603014D1 (de) Verfahren zur herstellung von niedermolekularem, hochreaktivem polyisobuten
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE69618476D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69001968D1 (de) Verfahren zur erzeugung von wasserstoffperoxyd.
DE69604277D1 (de) Verfahren zur herstellung von nootkaton
ATE271070T1 (de) Verfahren zur herstellung eines metallocen- katalysatorsystems
DE59602289D1 (de) Verfahren zur herstellung von halogenfreiem, reaktivem polyisobuten
DE68904625D1 (de) Verfahren zur herstellung von wasserstoffperoxid.
DE69605064D1 (de) Verfahren zur Herstellung von Wasserstoffperoxid
DE69808771D1 (de) Ein verfahren zur herstellung von tetraaza makrocyclen
ATE182143T1 (de) Verfahren zur herstellung von 1,2- benzisothiazolonen
EP0882026A4 (de) Verfahren zur herstellung von dihydropyrimidonen
DE68916022D1 (de) Verfahren zur herstellung von wasserstoffgas.
DE59807664D1 (de) Verfahren zur herstellung von 3-cyano-2,4-dihalogen-5-fluor-benzoesäuren
ATE211716T1 (de) Verfahren zur herstellung von feinverteiltes metallisches kobalt enthaltendem kobalt(ii)-oxid
ATE269863T1 (de) Verfahren zur herstellung von granisetron
DE69611843D1 (de) Verfahren zur herstellung von 2-buten-1,4-diol
ATE187450T1 (de) Verfahren zur herstellung von benzo(b)thiophenen
ATE163181T1 (de) Verfahren zur herstellung von 2- cyaniminothiazolidin
DE68901996D1 (de) Verfahren zur herstellung von pyruvat.
ATE304298T1 (de) Verfahren zur herstellung von fleischprodukten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0828717

Country of ref document: EP